Examination Report |
1 | TM-1 | 02 Jun 2010 |
10 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 12 Aug 2021 |
11 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 28 Feb 2022 |
12 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 01 Mar 2022 |
13 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 02 Jan 2023 |
14 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 13 Jun 2023 |
15 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 14 Dec 2023 |
16 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 14 Jun 2024 |
2 | Correspondence | 03 Jan 2011 |
3 | TM-16 | 18 Feb 2011 |
4 | TM-5 | 11 Apr 2011 |
5 | TM-56 | 09 Jan 2013 |
6 | TM-16 | 08 Feb 2017 |
7 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 24 Apr 2020 |
8 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 15 May 2020 |
9 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 01 Mar 2021 |
As per IP India data the trademark was applied on 02 June 2010.
ABBOTT HEALTHCARE applied for Diclofam.
Listed class of trademark Diclofam is 5.
Diclofam is on the Opposed stage of the trademark process.
Serial Number provided to trademark application is 1974224
Trademark application was filed by the following attorney agent:
Zeusip
The trademark is categorized as WORD.